These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 30340628)

  • 1. I do not want to suppress the natural process of inflammation: new insights on factors associated with non-adherence in rheumatoid arthritis.
    Ritschl V; Lackner A; Boström C; Mosor E; Lehner M; Omara M; Ramos R; Studenic P; Smolen JS; Stamm TA
    Arthritis Res Ther; 2018 Oct; 20(1):234. PubMed ID: 30340628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rheumatologists' insight into medication adherence in patients with rheumatoid arthritis: A qualitative study.
    Heidari P; Cross W; Weller C; Team V; Nazarinia M; Crawford K
    Int J Rheum Dis; 2019 Sep; 22(9):1695-1705. PubMed ID: 31322831
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 'The lesser of two evils…' - views of persons with rheumatoid arthritis on medication adherence: a qualitative study.
    Brandstetter S; Hertig S; Loss J; Ehrenstein B; Apfelbacher C
    Psychol Health; 2016 Jun; 31(6):675-92. PubMed ID: 26832226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-adherence in difficult-to-treat rheumatoid arthritis from the perspectives of patients and rheumatologists: a concept mapping study.
    Roodenrijs NMT; van der Goes MC; Welsing PMJ; van Oorschot EPC; Nikiphorou E; Nijhof NC; Tekstra J; Lafeber FPJG; Jacobs JWG; van Laar JM; Geenen R
    Rheumatology (Oxford); 2021 Nov; 60(11):5105-5116. PubMed ID: 33560301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of patients at risk of non-adherence to oral antirheumatic drugs in rheumatoid arthritis using the Compliance Questionnaire in Rheumatology: an ARCO sub-study.
    Marras C; Monteagudo I; Salvador G; de Toro FJ; Escudero A; Alegre-Sancho JJ; Raya E; Ortiz A; Carmona L; Mestre Y; Cea-Calvo L; Calvo-Alén J
    Rheumatol Int; 2017 Jul; 37(7):1195-1202. PubMed ID: 28516236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of Medication Beliefs, Self-efficacy, and Adherence in a Diverse Cohort of Adults with Rheumatoid Arthritis.
    McCulley C; Katz P; Trupin L; Yelin EH; Barton JL
    J Rheumatol; 2018 Dec; 45(12):1636-1642. PubMed ID: 30219761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adherence rates and associations with nonadherence in patients with rheumatoid arthritis using disease modifying antirheumatic drugs.
    van den Bemt BJ; van den Hoogen FH; Benraad B; Hekster YA; van Riel PL; van Lankveld W
    J Rheumatol; 2009 Oct; 36(10):2164-70. PubMed ID: 19723906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medication adherence in patients with rheumatoid arthritis: why do patients not take what we prescribe?
    Wong PK
    Rheumatol Int; 2016 Nov; 36(11):1535-1542. PubMed ID: 27665289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psychosocial predictors of DMARD adherence in the first three months of treatment for early arthritis.
    Pasma A; Hazes JM; Busschbach JJ; van der Laan WH; Appels C; de Man YA; Nieboer D; Timman R; van 't Spijker A
    Patient Educ Couns; 2017 Jan; 100(1):126-132. PubMed ID: 27516438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Motivations for inadequate persistence with disease modifying anti-rheumatic drugs in early rheumatoid arthritis: the patient's perspective.
    Pascual-Ramos V; Contreras-Yáñez I
    BMC Musculoskelet Disord; 2013 Dec; 14():336. PubMed ID: 24289729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rheumatoid Arthritis Patients' Motivations for Accepting or Resisting Disease-Modifying Antirheumatic Drug Treatment Regimens.
    Shaw Y; Metes ID; Michaud K; Donohue JM; Roberts MS; Levesque MC; Chang JC
    Arthritis Care Res (Hoboken); 2018 Apr; 70(4):533-541. PubMed ID: 28575542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medication effectiveness with the use of tumor necrosis factor inhibitors among Texas Medicaid patients diagnosed with rheumatoid arthritis.
    Oladapo A; Barner JC; Lawson KA; Novak S; Rascati KL; Richards KM; Harrison DJ
    J Manag Care Spec Pharm; 2014 Jul; 20(7):657-67. PubMed ID: 24967519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High degree of nonadherence to disease-modifying antirheumatic drugs in patients with rheumatoid arthritis.
    Rauscher V; Englbrecht M; van der Heijde D; Schett G; Hueber AJ
    J Rheumatol; 2015 Mar; 42(3):386-90. PubMed ID: 25593229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determinants of adherence to disease modifying anti-rheumatic drugs in White British and South Asian patients with rheumatoid arthritis: a cross sectional study.
    Kumar K; Raza K; Nightingale P; Horne R; Chapman S; Greenfield S; Gill P
    BMC Musculoskelet Disord; 2015 Dec; 16():396. PubMed ID: 26714853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contribution of Personality Traits, Psychological Factors, and Health-Related Quality of Life to Medication Adherence in Patients with Rheumatoid Arthritis.
    Ko KM; Moon SJ; Koh JH; Pae CU; Min JK
    Yonsei Med J; 2020 May; 61(5):406-415. PubMed ID: 32390364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multilevel factors predict medication adherence in rheumatoid arthritis: a 6-month cohort study.
    Balsa A; García de Yébenes MJ; Carmona L;
    Ann Rheum Dis; 2022 Mar; 81(3):327-334. PubMed ID: 34844924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Examining Time to Initiation of Biologic Disease-modifying Antirheumatic Drugs and Medication Adherence and Persistence Among Texas Medicaid Recipients With Rheumatoid Arthritis.
    Kim G; Barner JC; Rascati K; Richards K
    Clin Ther; 2016 Mar; 38(3):646-54. PubMed ID: 26899313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Barriers and facilitators to disease-modifying antirheumatic drug use in patients with inflammatory rheumatic diseases: a qualitative theory-based study.
    Voshaar M; Vriezekolk J; van Dulmen S; van den Bemt B; van de Laar M
    BMC Musculoskelet Disord; 2016 Oct; 17(1):442. PubMed ID: 27769224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of adherence to disease-modifying anti-rheumatic drugs in rheumatoid arthritis.
    Monchablon C; Gondé H; Pouplin S; Varin R; Vittecoq O; Lequerré T
    Clin Rheumatol; 2020 Jan; 39(1):207-216. PubMed ID: 31768668
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medication adherence and cost-related medication non-adherence in patients with rheumatoid arthritis: A cross-sectional study.
    Heidari P; Cross W; Weller C; Nazarinia M; Crawford K
    Int J Rheum Dis; 2019 Apr; 22(4):555-566. PubMed ID: 30924291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.